Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer
2017 · Molecular Therapy — Nucleic Acids · 93 citations
https://doi.org/10.1016/j.omtn.2017.12.015
H
Haitao Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
135
Papers
1.8K
Citations
25
h-index
53
i10-index
Haitao Liu is an academic researcher from First Affiliated Hospital of Bengbu Medical College. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Ferroptosis and cancer prognosis & Cancer-related molecular mechanisms research. The author has an h-index of 25, co-authored 115 publications.
ORCID: 0000-0002-3674-0081Papers by this author
worksCo-targeting EGFR and survivin with a bivalent aptamer-dual siRNA chimera effectively suppresses prostate cancer
2016 · Scientific Reports · 68 citations
https://doi.org/10.1038/srep30346
The challenges and opportunities of αvβ3-based therapeutics in cancer: From bench to clinical trials
2023 · Pharmacological Research · 58 citations
https://doi.org/10.1016/j.phrs.2023.106694
The cancer‐associated fibroblasts related gene CALD1 is a prognostic biomarker and correlated with immune infiltration in bladder cancer
2021 · Cancer Cell International · 57 citations
https://doi.org/10.1186/s12935-021-01896-x
Upregulation of MicroRNA-214 Contributes to the Development of Vascular Remodeling in Hypoxia-induced Pulmonary Hypertension Via Targeting CCNL2
2016 · Scientific Reports · 48 citations
https://doi.org/10.1038/srep24661
Cancer spheroids derived exosomes reveal more molecular features relevant to progressed cancer
2021 · Biochemistry and Biophysics Reports · 23 citations
https://doi.org/10.1016/j.bbrep.2021.101026
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat